Medpage Today on MSN15h
Myasthenia Gravis Patients May Use Less Steroids After Starting Efgartigimod
SAVANNAH, Ga. -- One year after starting efgartigimod (Vyvgart) treatment, most generalized myasthenia gravis (gMG) patients ...
MedPage Today on MSN1d
Sustained Disease Control in Adolescent Myasthenia Gravis With FcRn Blocker
The findings, presented at the Myasthenia Gravis Foundation of America (MGFA) session of the American Association of ...
Medscape4d
First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis
A first-in-class anti-CD19 B-cell depleting agent was safe and demonstrated superior efficacy vs placebo in patients with ...
Medscape4d
Sustained Control With Investigational Monoclonal Antibody for Myasthenia Gravis
The investigational monoclonal antibody nipocalimab is associated with significant improvement in patients with generalized ...
Medpage Today on MSN5d
Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis
Investigational nipocalimab lessened disease severity in generalized myasthenia gravis (gMG), the phase III Vivacity-MG3 ...
PharmiWeb5d
Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia gravis in the Phase 2/3 study
For immediate release Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia ...
AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
Amgen (NASDAQ:AMGN) today announced the presentation of positive top-line results from the Phase 3 MINT trial evaluating the ...
FierceBiotech5d
J&J, with adult approval in sight, posts adolescent myasthenia gravis data on $6.5B FcRn blocker
Johnson & Johnson has burnished the evidence for nipocalimab, adding a sliver of data in adolescents with generalized ...
Morningstar6d
UCB announces U.S. launch of UCB Myasthenia Gravis Scholarship™ for people impacted by myasthenia gravis in the U.S.
Applications are now open for submission at www.UCBMGSCHOLARSHIP.com The UCB U.S. Myasthenia Gravis Scholarship is open to eligible applicants who intend to pursue educational opportunities such ...
Amgen Reports Positive Phase 3 Data For Uplizna In Generalized Myasthenia Gravis
Tuesday announced positive topline data from the Phase 3 MINT study evaluating Uplizna for the treatment of adults ...